Besides, there have been reports indicating that Tregs inhibits the cytotoxicity of CD8+ T cells, resulting in a negative outcome for HCC (Moghaddam et al., 2022; Zheng et al., 2017). Here, CD8A is linked to hepatocellular carcinoma.